Fc receptor blockade in patients with refractory chronic immune thrombocytopenic purpura with anti-D IgG

Archives of Medical Research

Volumn 33, Issue 6, 2002, Pages 536-540

  Ambriz Fernández, Raúl ^a,b   Martínez Murillo, Carlos ^a   Quintana González, Sandra ^a,b   Collazo Jaloma, Juan ^a   Bautista Juárez, Javier ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Anti D (IgG) coated red blood cells; Chronic refractory ITP; FcR blockade; Immune thrombocytopenic purpura; Immune thrombocytopenic purpura treatment

Indexed keywords

FC RECEPTOR; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COOMBS TEST; DOSE RESPONSE; ERYTHROCYTE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SPLENECTOMY; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC; RECEPTORS, FC; RHO(D) IMMUNE GLOBULIN; SPLEEN; TIME FACTORS;

EID: 0036866268     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(02)00412-5     Document Type: Article

References (25)

1. George J.N., Raskob G.E. Idiopathic thrombocytopenia purpura. a concise summary of the pathophysiology and diagnosis in children and adults Semin Hematol. 36:1998;5-8.
2. Harrington W.J., Sprague C.C., Minnich V. Immunological mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med. 38:1953;433-469.
3. Shulman N.R., Marder V.J., Weinrach R.S. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. physiologic, serologic, and isotopic studies Ann N Y Acad Sci. 124:1965;499-542.
4. McMillan R. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura. Semin Hematol. 37:2000;5-9.
5. Pizzuto J., Ambríz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura. multicentric trial of the Cooperative Latin American Group on Hemostasis and Thrombosis Blood. 64:1984;1179-1183.
6. Kelton J.G., Bussel J.B. Idiopathic immune thrombocytopenic purpura. An update. Semin Hematol. 37:2000;219-221.
7. Bussel J.B. Recent advances in the treatment of idiopathic thrombocytopenic purpura. the anti-D clinical experience Semin Hematol. 36:1998;1-4.
8. Bussel J.B. Fc receptor blockade and immune thrombocytopenic purpura. Semin Hematol. 37:2000;261-266.
9. Salama A., Kiefel V., Amberg R., Müeller-Eckhardt C. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-RhO [D]). Blut. 49:1984;29-35.
10. Salama A., Kiefel V., Müeller-Eckhardt C. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol. 22:1986;241-250.
11. Baglin T.P., Smith M.P., Boughton B.J. Rapid and complete response of immune thrombocytopenic purpura to a single injection of rhesus anti-D immunoglobulin. Lancet. 1:1986;1329-1330.
12. Panzer S., Grumayer E.R., Haas O.A., Niesner H., Graninger W. Efficacy of rhesus antibodies (Anti-Rho (D) in autoimmune thrombocytopenia. correlation with response to high dose IgG and the degree of haemolysis Blut. 52:1986;117-121.
13. Gabra G.S., Mitchell R. Anti-D immunoglobulin and immune thrombocytopenia - a problem of ethics in blood transfusion practice. Vox Sang. 54:1988;246-248.
14. Bussel J.B., Graziano J.N., Kimberly R.P., Pahwa S., Aledort L. Intravenous anti-D treatment of immune thrombocytopenic purpura. analysis of efficacy, toxicity and mechanism of effect Blood. 77:1991;1884-1893.
15. Ware R.E., Zimmerman S.A. Anti-D. mechanisms of action Semin Hematol. 36:1998;14-22.
16. George J.N., El-Harake M.A., Aster R. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. Williams hematology. 5th ed:1995;1315-1355 McGraw-Hill, Inc, New York.
17. Ruíz-Argüelles G.J., Apreza M.M.G., Pérez-Romano B., Ruíz-Argüelles G. The infusion of anti-Rho (D) opsonized erythrocytes may be useful in the treatment of patients, splenectomized or not, with chronic, refractory autoimmune thrombocytopenic purpura. A prospective study. Am J Hematol. 43:1993;72-73.
18. Ambríz R., Pizzuto J., Morales M., Muñoz R., Quintanar G., García E. Treatment of chronic ITP with opsonized erythrocytes with rhesus antibody and labeled with Tc-99m (radioimmune method). Blood. n64(Suppl):1984;233.
19. Ambríz R., Muñoz R., Quintanar E., Sigler L., Avilés A., Pizzuto J. Accessory spleen compromising response to splenectomy for idiopathic thrombocytopenic purpura. Radiology. 155:1985;793-796.
20. Ambríz R, Muñoz R, Quintanar E, Sigler L, Avilés A, Pizzuto J. Accessory spleen compromising response to splenectomy for idiopathic thrombocytopenic purpura. In: The Year Book of Nuclear Medicine. Chicago, IL, USA: Year Book Medical Publishers, Inc.;1987. pp. 326-327.
21. Ambríz R., Muñoz R., Pizzuto J., Quintanar E., Morales M., Avilés A. Low-dose autologous in vitro opsonized erythrocytes. Radioimmune method and autologous opsonized erythrocytes for refractory autoimmune thrombocytopenic purpura in adults. Arch Intern Med. 147:1987;105-108.
22. Mollison PL, Engelfriet CP, Contreras M. The transfusion of platelets, leukocytes and plasma components. Injections of immunoglobulin. In: Blood Transfusion in Clinical Medicine. 9th Ed. London: Blackwell Scientific Publications;1993. pp. 673-674.
23. Smith N.A., Boughton B.J. The treatment of autoimmune thrombocytopenic purpura with anti-D immunoglobulin. similar platelet responses in homozygous and heterozygous Rh(D) positive patients Transfus Med. 1:1991;183-185.
24. Scaradavou A., Woo B., Woloski B.M. Intravenous anti-D treatment of immune thrombocytopenic purpura experience in 272 patients. Blood. 89:1997;2689-2700.
25. Ruíz-Argüelles G., López-Martínez B., Flores-Martínez J., Ruíz-Argüelles A., Pérez-Romano B. An affordable Fc-receptor blockade method to treat patients with chronic refractory autoimmune thrombocytopenic purpura. Haematologica. 86:2001;552-553.